<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4796761</article-id><article-id pub-id-type="publisher-id">568</article-id><article-id pub-id-type="doi">10.1186/2197-425X-3-S1-A424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Automation of oxygen titration in patients with acute respiratory distress at the emergency department. A multicentric international randomised controlled study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>L'Her</surname><given-names>E</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Dias</surname><given-names>P</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Gouillou</surname><given-names>M</given-names></name><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Paleiron</surname><given-names>N</given-names></name><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Archambault</surname><given-names>P</given-names></name><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Bouchard</surname><given-names>P-A</given-names></name><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lellouche</surname><given-names>F</given-names></name><xref ref-type="aff" rid="Aff6"/></contrib><aff id="Aff1"><label/>CHRU Brest, Brest, France </aff><aff id="Aff2"><label/>CHRU Brest, CIC INSERM 1412, Brest, France </aff><aff id="Aff3"><label/>HIA Clermont-Tonnerre, Brest, France </aff><aff id="Aff4"><label/>H&#x000f4;tel Dieu, L&#x000e9;vis, Canada </aff><aff id="Aff5"><label/>Institut Universitaire de Cardiologie et de Pneumologie de Qu&#x000e9;bec, Qu&#x000e9;bec, Canada </aff><aff id="Aff6"><label/>Institut Universitaire de Cardiologie et de Pneumologie de Qu&#x000e9;bec, Lac-Beauport, Canada </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2015</year></pub-date><volume>3</volume><issue>Suppl 1</issue><issue-sponsor>The publication charges for this supplement were funded by Intensive Care Medicine Experimental.</issue-sponsor><elocation-id>A424</elocation-id><permissions><copyright-statement>&#x000a9; L'Her et al.; 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><conference><conf-name>ESICM LIVES 2015</conf-name><conf-loc>Berlin, Germany</conf-loc><conf-date>3-7 October 2015</conf-date><string-conf><uri>http://www.esicm.org/</uri></string-conf></conference><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Oxygen therapy is commonly administered in critical care and emergency medicine. Its benefits are well known but potential side-effects may be underestimated. Compliance to recommendations remains dependent on staff workload. We developed FreeO<sub>2</sub>, an innovative device that automatically titrates oxygen flow delivered through nasal cannulas or masks to maintain the patients in the SpO<sub>2</sub> target set by the clinician<sup>1</sup>.</p></sec><sec id="Sec2"><title>Objectives</title><p>To compare FreeO<sub>2</sub> with oxygen manual adjustment, in patient admitted to the emergency department (ED) for acute respiratory failure (ARF).</p></sec><sec id="Sec3"><title>Methods</title><p>We conducted a multicentre randomized controlled study. Inclusion criteria were: admission to ED for ARF requiring O<sub>2</sub>&#x02265;3L/min. Main exclusion criteria were: O<sub>2</sub>&#x02265;15 L/min, immediate need for ventilatory support. After inclusion, patients were randomized to either FreeO<sub>2</sub> or conventional O<sub>2</sub> manual adjustment during 3 hours. The randomization was web-based and stratified for the type of respiratory failure (hypoxemia/hypercapnia) and for the centre. Primary outcome was the % of time with SpO<sub>2</sub> within the predefined target (92-96% for hypoxemic patients; 88-92% for hypercapnic patients). Secondary endpoints were: frequency of severe hypoxemia (SpO<sub>2</sub> &#x0003c; 85%) and hyperoxia (SpO<sub>2</sub>&#x0003e; 98%), partial or complete oxygen weaning at the ED, total O<sub>2</sub> duration, ventilator support use, ICU admissions, ICU and hospital LOS.</p></sec><sec id="Sec4"><title>Results</title><p>187 patients were randomized (93 FreeO<sub>2</sub> and 94 Manual). Baseline physiological characteristics were similar in the 2 groups: age = 76 &#x000b1; 12 yrs., 35% of COPD patients; mean O<sub>2</sub> flow at inclusion was 5.8 &#x000b1; 3.1 L/min. No serious adverse events related to the protocol or device was recorded. The percentage of time within the SpO<sub>2</sub> target was 81 &#x000b1; 21% in the FreeO<sub>2</sub> arm and 51 &#x000b1; 30% in the Manual arm (P &#x0003c; 0.001). Percentage of time with severe hypoxemia and with hyperoxia were significantly lower with FreeO<sub>2</sub> (P &#x0003c; 0.001). The percentage of patients with O<sub>2</sub> flow reduction of more than 50% during the 3 hours of the study was 39% with FreeO<sub>2</sub> vs 19% in the Manual arm (P = 0.011). Percentage of O<sub>2</sub> weaning at the end of the study (3h) was 4.3% in the FreeO<sub>2</sub> arm vs. 14.1 % in the Manual arm; p &#x0003c; 0.001. Significantly less patients in the hypercapnic subgroup were transferred in the ICU, overall O<sub>2</sub> administration and hospital LOS were significantly reduced in the non-adjusted analysis (9.2 &#x000b1; 6.9 vs 11.1 &#x000b1; 7.0, P = 0.01).</p></sec><sec id="Sec5"><title>Conclusions</title><p>The automation of oxygen therapy with FreeO<sub>2</sub> at the ED improves the oxygenation parameters with more time in the specified SpO<sub>2</sub> target, less desaturation and less hyperoxia. FreeO<sub>2</sub> may reduce staff workload and improve the compliance to recommendations for oxygen administration with potential related clinical benefits</p></sec><sec id="Sec6"><title>Grant Acknowledgment</title><p><italic>PHRC National 2010 FreeO2 Hypox #08-12</italic></p><p><italic>Grant PSR-SIIRI-MDEIE (Ministry of Finances, Qu&#x000e9;bec)</italic></p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lellouche</surname><given-names>F</given-names></name><name><surname>L&#x02019;her</surname><given-names>E</given-names></name></person-group><article-title>Automated oxygen flow titration to maintain constant oxygenation</article-title><source>Respir Care</source><year>2012</year><volume>57</volume><issue>8</issue><fpage>1254</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.4187/respcare.01343</pub-id><pub-id pub-id-type="pmid">22348812</pub-id></element-citation></ref></ref-list></back></article>